Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2007

View Archived Issues

Assessing the efficacy of new drugs for multiple sclerosis in clinical trials: II

Novel therapeutic options for metabolic disorders described in recent patents

Atorvastatin may increase multiple sclerosis activity

Novel therapeutic agents for respiratory disorders described in recent patents

UK-371804: a novel selective urokinase-type plasminogen activator inhibitor from Pfizer

Plant-produced smallpox subunit vaccine protects mice against lethal vaccinia virus challenge

ABS-75: a novel fullerene derivative with neuroprotective activity in vivo

GenVec obtains additional funding for malaria vaccine program

In vivo imaging of primate brain with novel adenosine A2 receptor radioligand

AL-39324 reduces ocular angiogenesis in different animal models in vivo

Sunesis earns preclinical milestone payment in BACE collaboration with Merck

Nucleonics cleared for phase I study of eiRNA therapy for chronic HBV

AVI and Ercole collaborate in DMD and beta thalassemia

RegeneRx cleared to begin cardiovascular program for Tbeta4

Positive findings from preclinical testing of caprospinol

Array begins phase I cancer study for ARRY-520

Enrollment completed in phase II study of MBP-8298 for relapsing-remitting MS

Novavax obtains positive results for pandemic influenza vaccine in ferrets

AeroLEF shows statistically significant difference in SPRID4 in postoperative pain

Immunotherapy with MHC II-expressing tumor cells may be useful in uveal melanoma

New antithrombotic agents disclosed in recent sanofi-aventis Deutschland patent

SR Pharma changes name to Silence Therapeutics

Spectrum cleared to add Canadian sites to BPH program for ozarelix

Chugai elects to copromote Actemra in France, Germany and U.K

FDA approves new indication for Fragmin

Approvable letter for CIP-Tramadol ER

Fast track designation for pixantrone in relapsed or refractory NHL

Abbott seeks U.S. and E.U. approvals for Humira in juvenile rheumatoid arthritis

Pylera launched for eradication of H. pylori

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...